C4.4A
Anterior gradient 2 (AGR2) promotes cancer growth, metastasis, and resistance to therapy via unknown mechanisms. We investigated the effects of extracellular AGR2 signaling through the orphan glycosylphosphatidylinositol-linked receptor C4.4A in pancreatic ductal adenocarcinoma (PDAC).
Derivation: Human
Type: scFv
Application: ELISA, WB, FC, FuncS
Compare
Derivation: Human
Type: IgG
Application: ELISA, WB, IF, FuncS
Compare
Derivation: Mouse
Type: scFv
Application: IP, IF, Biosensors, FuncS
Compare
Derivation: Mouse
Type: Fab
Application: WB, RIA, FuncS
Compare
Derivation: Mouse
Type: IgG
Application: WB, IP, FuncS
Compare
Derivation: Human
Type: Fab
Application: IF, WB, FuncS
Compare
Species Reactivity: Human
Type: Mouse IgG2b, κ
Application: FuncS
Compare
Species Reactivity: Human
Type: Mouse Fab
Application: FuncS
Compare
Species Reactivity: Human
Type: Mouse scFv
Application: FuncS
Compare
Target: C4.4a
Linker: lysine
Drug: toxophore loading
Compare
Target: C4.4a
Linker: lysine
Drug: toxophore loading
Compare
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.